SEC Form D · filed March 6, 2023
ADIAL PHARMACEUTICALS, INC
Location
CHARLOTTESVILLE, VA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
William B. Stilley, Iii · Charlottesville, VADirectorJames K. Anderson · Charlottesville, VADirectorBankole A. Johnson · Charlottesville, VAExecCary J. Claiborne · Charlottesville, VAExec · DirectorRobertson H. Gilliland · Charlottesville, VADirectorKevin W. Schuyler, Cfa · Charlottesville, VADirectorJames W. Newman, Jr · Charlottesville, VADirectorJoseph M. Truluck · Charlottesville, VAExecTony W. Goodman · Charlottesville, VADirectorElaine Ellingham · Toronto, Ontario, CanadaExec · DirectorKweli Washington · New York, NYDirectorJason Bergsman · Playa Vista, CAExecW. C. Mccollum · Los Angeles, CAExecSever Totia · New York, NYDirectorPeter Feld · New York, NYDirectorRonald Heffernan · Sandy, UTDirectorJesse S. Jacobs · Playa Vista, CADirectorMike Kerns · Playa Vista, CADirectorUrsula Newman · London, United KingdomExecThomas Scriven · Golden, CODirectorMatthew Davis · Purcellville, VADirectorFred Ausubel · Allston, MAExecCory Brown · Nashville, TNDirectorLauren Smith · Nashville, TNDirectorKiran N. Bhatraju · Shepherdstown, WVDirectorMatthew Tomich · New York, NYDirectorLee Hower · Boston, MAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗